発表論文

論文 (英文誌)


  1. Development and accuracy evaluation of a degree of occlusion visualization system for roller pumps used in cardiopulmonary bypass, Aoi Fukaya, Yasuyuki Shiraishi, Yusuke Inoue, Akihiko Yamada, Genta Sahara, Takemi Kudo, Yasuhiro Aizawa, Tomoyuki Yambe , Journal of Artificial Organs, 2020https://doi.org/10.1007/s10047-020-01211-x

  2. Optimum Sterilization Methods of Biocompatible Hybrid Material for Artificial Organs, Yusuke Inoue, Ayaka Tashiro, Yukino Kawase, Takashi Isoyama, Itsuro Saito, Toshiya Ono, Shintaro Hara, Kohei Ishii, Terumi Yurimoto, Yasuyuki Shiraishi, Akihiro Yamada, Tomoyuki Yambe, Yusuke Abe, Advanced Biomedical Engineering, 9, 83-92, 2020doi.org/10.14326/abe.9.83

  3. Mathematical evaluation of cardiac beat synchronization control used for a rotary blood pump., Ogawa D, Kobayashi S, Yamazaki K, Motomura T, Nishimura T, Shimamura J, Tsukiya T, Mizuno T, Takewa Y, Tatsumi E., J Artif Organs., Dec;22(4):276-285. 2019

  4. Interventricular dyssynchrony during continuous-flow left ventricular assist device support: observation using the conductance method., Shimamura J, Nishimura T, Mizuno T, Takewa Y, Tsukiya T, Inatomi A, Katagiri N, Ando M, Umeki A, Akiyama D, Arakawa M, Ono M, Tatsumi E., J Artif Organs., Dec;22(4):348-352. 2019

  5. Quantification of interventricular dyssynchrony during continuous-flow left ventricular assist device support., Shimamura J, Nishimura T, Mizuno T, Takewa Y, Tsukiya T, Inatomi A, Ando M, Umeki A, Naito N, Ono M, Tatsumi E., J Artif Organs. , Dec;22(4):269-275. 2019

  6. Miniaturized centrifugal ventricular assist device for bridge to decision: preclinical chronic study in a bovine model., Shimamura J, Mizuno T, Takewa Y, Tsukiya T, Naito N, Akiyama D, Iiduka K, Katagiri N, Nishimura T, Ono M, Tatsumi E. *, Artif Organs. , Mar 20. doi: 10.1111/aor.13459. [Epub ahead of print] 2019 　　　　　　　　

  7. Implanted In-Body Tissue-Engineered Heart Valve Can Adapt the Histological Structure to the Environment. , Takewa Y, * Sumikura H, Kishimoto S, Naito N, Iizuka K, Akiyama D, Iwai R, Tatsumi E, Nakayama Y. , ASAIO J. , May/Jun;64(3), 395-405. 2018

  8. Optimal drainage cannula position in dual cannulation for veno-venous extracorporeal membrane oxygenation., Togo K, Takewa Y, Katagiri N, Fujii Y, Yamashita AC, Tastumi E. *, Int J Artif Organs. , Dec;41(12):867-871. 2018 　

  9. Accurate Method of Quantification of Aortic Insufficiency During Left Ventricular Assist Device Support by Thermodilution Analysis: Proof of Concept and Validation by a Mock Circulatory System., Akiyama D, Nishimura T, Sumikura H, Iizuka K, Mizuno T, Tsukiya T, Takewa Y, Ono M, Tatsumi E. *, Artif Organs. , Oct;42(10):954-960. 2018

  10. The angle of the outflow graft to the aorta can affect recirculation due to aortic insufficiency under left ventricular assist device support., Iizuka K, Nishinaka T, Akiyama D, Sumikura H, Mizuno T, Tsukiya T, Takewa Y, Yamazaki K, Tatsumi E.*, J Artif Organs. , Dec;21(4):399-404. 2018 　　　　　　　　

  11. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial., Fukushima N, Tatsumi E, Seguchi O, Takewa Y, Hamasaki T, Onda K, Yamamoto H, Hayashi T, Fujita T, Kobayashi J. *, Cardiovasc Drugs Ther. , Aug;32(4):373-379. 2018

  12. Left heart pressures can be the key to know the limitation of left ventricular assist device support against progression of aortic insufficiency., Iizuka K, Nishinaka T, Naito N, Akiyama D, Takewa Y, Yamazaki K, Tatsumi E. *, J Artif Organs., Sep;21(3):265-270. 2018

  13. Evaluation of the Novel Centrifugal Pump, CAPIOX SL, in Chronic Large Animal Experiments., Iizuka K, Katagiri N, Takewa Y, Tsukiya T, Mizuno T, Itamochi Y, Kumano K, Tatsumi E. *, Artif Organs. , Aug;42(8):835-841. 2018

  14. Preclinical animal study of the NIPRO-ventricular assist device for use in pediatric patients., Naito N, Takewa Y, Kishimoto S, Iizuka K, Mizuno T, Tsukiya T, Ono M, Tatsumi E. *, J Artif Organs., Jun;21(2):156-163. 2018

  15. Differences in clotting parameters between species for preclinical large animal studies of cardiovascular devices., Mizuno T, Tsukiya T, Takewa Y, Tatsumi E. *, J Artif Organs. , Jun;21(2):138-141. 2018

  16. Rotational speed modulation used with continuous-flow left ventricular assist device provides good pulsatility., Naito N, Nishimura T, Iizuka K, Takewa Y, Umeki A, Ando M, Ono M, Tatsumi E. *, Interact Cardiovasc Thorac Surg. , Jan 1;26(1):119-123. 2018

  17. Novel temporary left ventricular assist system with hydrodynamically levitated bearing pump for bridge to decision: initial preclinical assessment in a goat model., Kishimoto S, Takewa Y, Tsukiya T, Mizuno T, Date K, Sumikura H, Fujii Y, Ohnuma K, Togo K, Katagiri N, Naito N, Kishimoto Y, Nakamura Y, Nishimura M, Tatsumi E. *, J Artif Organs., Mar;21(1):23-30. 2018

  18. Novel Rotational Speed Modulation System Used With Venoarterial Extracorporeal Membrane Oxygenation., Naito N, Nishimura T, Iizuka K, Fujii Y, Takewa Y, Umeki A, Ando M, Ono M, Tatsumi E. *, Ann Thorac Surg., Nov;104(5):1488-1495. 2017 　　　　

  19. The influence of pump rotation speed on hemodynamics and myocardial oxygen metabolism in left ventricular assist device support with aortic valve regurgitation. Apr 20., Iizuka K, Nishinaka T, Takewa Y, Yamazaki K, Tatsumi E. *, J Artif Organs. , Sep;20(3):194-199. 2017

  20. Effect of hydroxyethyl starch priming on the systemic inflammatory response and lung edema following cardiopulmonary bypass in a rat model., Fujii Y, Tanabe T, Yamashiro T, Shirai M, Takewa Y, Tatsumi E. *, ASAIO J. , Sep/Oct;63(5):618-623. 2017

  21. Changing pulsatility by delaying the rotational speed phasing of a rotary left ventricular assist device., Date K, Nishimura T, Arakawa M, Takewa Y, Kishimoto S, Umeki A, Ando M, Mizuno T, Tsukiya T, Ono M, Tatsumi E. *, J Artif Organs. , Mar;20(1):18-25. 2017

  22. Development of a stent-biovalve with round-shaped leaflets: in vitro hydrodynamic evaluation for transcatheter pulmonary valve implantation (TPVI)., Sumikura H, Nakayama Y, Ohnuma K, Takewa Y, Tatsumi E. * , J Artif Organs. , Dec;19(4):357-363. 2016

  23. What Is the Optimal Setting for a Continuous-Flow Left Ventricular Assist Device in Severe Mitral Regurgitation?, Naito N, Nishimura T, Takewa Y, Kishimoto S, Date K, Umeki A, Ando M, Ono M, Tatsumi E. *, Artif Organs. , Nov;40(11):1039-1045. 2016

  24. Shifting the pulsatility by increasing the change in rotational speed for a rotary LVAD using a native heart load control system., Date K, Nishimura T, Takewa Y, Kishimoto S, Arakawa M, Umeki A, Ando M, Mizuno T, Tsukiya T, Ono M, Tatsumi E. *, J Artif Organs., Dec;19(4):315-321. 2016

  25. Effects of feeding state on anticoagulation in adult goats treated with warfarin., Date K, Kishimoto S, Fujii Y, Togo K, Kakuta Y, Mizuno T, Tsukiya T, Takewa Y, Nishimura T, Ono M, Tatsumi E. *, J Artif Organs. , Sep;19(3):301-4. 2016

  26. Cardiopulmonary Bypass with Low- Versus High-Priming Volume: Comparison of Inflammatory Responses in a Rat Model., Fujii Y, Shirai M, Takewa Y, Tatsumi E. *, ASAIO J. , May-Jun;62(3):286-90. 2016

  27. Influence of a Rotational Speed Modulation System Used With an Implantable Continuous-Flow Left Ventricular Assist Device on von Willebrand Factor Dynamics., Naito N, Mizuno T, Nishimura T, Kishimoto S, Takewa Y, Eura Y, Kokame K, Miyata T, Date K, Umeki A, Ando M, Ono M, Tatsumi E. *, Artif Organs. , Sep;40(9):877-83. 2016

  28. Pulsatile support using a rotary left ventricular assist device with an electrocardiography-synchronized rotational speed control mode for tracking heart rate variability., Arakawa M, Nishimura T, Takewa Y, Umeki A, Ando M, Kishimoto Y, Kishimoto S, Fujii Y, Date K, Kyo S, Adachi H, Tatsumi E. *, J Artif Organs. , Jun;19(2):204-7. 2016

  29. Mechanical properties of human autologous tubular connective tissues (human biotubes) obtained from patients undergoing peritoneal dialysis., Nakayama Y, *Kaneko Y, Takewa Y, Okumura N., J Biomed Mater Res B Appl Biomater. , Oct;104(7):1431-7. 2016

  30. In vitro hydrodynamic evaluation of a biovalve with stent (tubular leaflet type) for transcatheter pulmonary valve implantation., Sumikura H, Nakayama Y, Ohnuma K, Kishimoto S, Takewa Y, Tatsumi E. *, J Artif Organs. , Dec;18(4):307-14. 2015

  31. Preclinical study of a novel hydrodynamically levitated centrifugal pump for long-term cardiopulmonary support : In vivo performance during percutaneous cardiopulmonary support., Tsukiya T, Mizuno T, Takewa Y, Tatsumi E, Taenaka Y. *, J Artif Organs. , Dec;18(4):300-6. 2015

  32. Development of self-expanding valved stents with autologous tubular leaflet tissues for transcatheter valve implantation., Funayama M, Sumikura H, Takewa Y, Tatsumi E, Nakayama Y. *, J Artif Organs. , Sep;18(3):228-35. 2015

  33. Sutureless aortic valve replacement using a novel autologous tissue heart valve with stent (stent biovalve): proof of concept., Kishimoto S, Takewa Y, Nakayama Y, Date K, Sumikura H, Moriwaki T, Nishimura M, Tatsumi E. *, J Artif Organs. , Jun;18(2):185-90. 2015

  34. A novel small animal extracorporeal circulation model for studying pathophysiology of cardiopulmonary bypass., Fujii Y, Shirai M, Inamori S, Takewa Y, Tatsumi E. *, J Artif Organs. , Mar;18(1):35-9. 2015

  35. In situ observation and enhancement of leaflet tissue formation in bioprosthetic "biovalve"., Funayama M, Takewa Y, Oie T, Matsui Y, Tatsumi E, Nakayama Y. *, J Artif Organs. , Mar;18(1):40-7. 2015

  36. Alternative approach for right ventricular failure after left ventricular assist device placement in animal model., Saito T, Toda K, Takewa Y, Tsukiya T, Mizuno T, Taenaka Y, Tatsumi E. *, Eur J Cardiothorac Surg., Jul;48(1):98-103. 2015

  37. Development of a flow rate monitoring method for the wearable ventricular assist device driver., Ohnuma K, Homma A, Sumikura H, Tsukiya T, Takewa Y, Mizuno T, Mukaibayashi H, Kojima K, Katano K, Taenaka Y, Tatsumi E. *, J Artif Organs. , Jun;18(2):128-35. 2015

  38. Impact of bypass flow rate and catheter position in veno-venous extracorporeal membrane oxygenation on gas exchange in vivo., Togo K, Takewa Y, Katagiri N, Fujii Y, Kishimoto S, Date K, Miyamoto Y, Tatsumi E. *, J Artif Organs. , Jun;18(2):128-35. 2015

  39. In-body tissue-engineered aortic valve (Biovalve type VII) architecture based on 3D printer molding., Nakayama Y, *Takewa Y, Sumikura H, Yamanami M, Matsui Y, Oie T, Kishimoto Y, Arakawa M, Ohmuma K, Tajikawa T, Kanda K, Tatsumi E., J Biomed Mater Res B Appl Biomater., Jan;103(1):1-11. 2015

  40. Influence of a novel electrocardiogram-synchronized rotational-speed-change system of an implantable continuous-flow left ventricular assist device (EVAHEART) on hemolytic performance., Kishimoto S, Date K, Arakawa M, Takewa Y, Nishimura T, Tsukiya T, Mizuno T, Katagiri N, Kakuta Y, Ogawa D, Nishimura M, Tatsumi E. *, J Artif Organs. , Dec;17(4):373-7. 2014

  41. Alternation of left ventricular load by a continuous-flow left ventricular assist device with a native heart load control system in a chronic heart failure model., Arakawa M, Nishimura T, Takewa Y, Umeki A, Ando M, Adachi H, Tatsumi E. *, J Thorac Cardiovasc Surg., Jan 15. pii: S0022-5223(14)00025-7. 2014

  42. Novel control system to prevent right ventricular failure induced by rotary blood pump., Arakawa M, Nishimura T, Takewa Y, Umeki A, Ando M, Kishimoto Y, Fujii Y, Kyo S, Adachi H, Tatsumi E. *, J Artif Organs. , Jun;17(2):135-41. 2014

  43. In vitro evaluation of a novel autologous aortic valve (biovalve) with a pulsatile circulation circuit., Sumikura H, Nakayama Y, Ohnuma K, Takewa Y, Tatsumi E. *, Artif Organs., Apr;38(4):282-9. 2014

  44. Preparation of an autologous heart valve with a stent (stent-biovalve) using the stent eversion method., Mizuno T, Takewa Y, Sumikura H, Ohnuma K, Moriwaki T, Yamanami M, Oie T, Tatsumi E, Uechi M, Nakayama Y. *, J Biomed Mater Res B Appl Biomater., Jul;102(5):1038-45. 2014

  45. In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model., Takewa Y, Yamanami M, Kishimoto Y, Arakawa M, Kanda K, Matsui Y, Oie T, Ishibashi-Ueda H, Tajikawa T, Ohba K, Yaku H, Taenaka Y, Tatsumi E, Nakayama Y. *, J Artif Organs. , Jun;17(2):135-41.41. 2014

  46. Hyperoxic condition promotes an inflammatory response during cardiopulmonary bypass in a rat model., Fujii Y, Shirai M, Tsuchimochi H, Pearson JT, Takewa Y, Tatsumi E, Taenaka Y. *, Artif Organs., Dec;37(12):1034-40. 2013

  47. Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis., Ladage D, Yaniz-Galende E, Rapti K, Ishikawa K, Tilemann L, Shapiro S, Takewa Y, Muller-Ehmsen J, Schwarz M, Garcia MJ, Sanz J, Hajjar RJ, *Kawase Y., PLoS One., May 20;8(5):e59656. 2013

  48. Development and evaluation of endurance test system for ventricular assist devices., Sumikura H, Homma A, Ohnuma K, Taenaka Y, Takewa Y, Mukaibayashi H, Katano K, Tatsumi E. *, J Artif Organs. , Jun;16(2):138-48. 2013

  49. Development of a novel drive mode to prevent aortic insufficiency during continuous-flow LVAD support by synchronizing rotational speed with heartbeat., Kishimoto Y, Takewa Y, Arakawa M, Umeki A, Ando M, Nishimura T, Fujii Y, Mizuno T, Nishimura M, Tatsumi E. *, J Artif Organs. , Jun;16(2):129-37. 2013

  50. Change in myocardial oxygen consumption employing continuous-flow LVAD with cardiac beat synchronizing system, in acute ischemic heart failure models., Umeki A, Nishimura T, Takewa Y, Ando M, Arakawa M, Kishimoto Y, Tsukiya T, Mizuno T, Kyo S, Ono M, Taenaka Y, Tatsumi E. *, J Artif Organs. , Jun;16(2):119-28. 2013

  51. Change of coronary flow by continuous-flow left ventricular assist device with cardiac beat synchronizing system (native heart load control system) in acute ischemic heart failure model. 　 [IF, 2.895; citation, 11], Umeki A, Nishimura T, Ando M, Takewa Y, Yamazaki K, Kyo S, Ono M, Tsukiya T, Mizuno T, Taenaka Y, Tatsumi E. *, Circ J., Mar 25;77(4):995-1000. 2013

  52. Insufflation of hydrogen gas restrains the inflammatory response of cardiopulmonary bypass in a rat model., Fujii Y, Shirai M, Inamori S, Shimouchi A, Sonobe T, Tsuchimochi H, Pearson JT, Takewa Y, Tatsumi E, Taenaka Y. *, Artif Organs., Feb;37(2):136-41. 2013

  53. Creating an ideal "off-test mode" for rotary left ventricular assist devices: establishing a safe and appropriate weaning protocol after myocardial recovery., Ando M, Nishimura T, Takewa Y, Kyo S, Ono M, Taenaka Y, Tatsumi E. *, J Thorac Cardiovasc Surg., May;143(5):1176-82. 2012

  54. Alteration of LV end-diastolic volume by controlling the power of the continuous-flow LVAD, so it is synchronized with cardiac beat: development of a native heart load control system (NHLCS)., Umeki A, Nishimura T, Ando M, Takewa Y, Yamazaki K, Kyo S, Ono M, Tsukiya T, Mizuno T, Taenaka Y, Tatsumi E. *, J Artif Organs. , Jun;15(2):128-33. 2012

  55. Effect of the technique for assisting renal blood circulation on ischemic kidney in acute cardiorenal syndrome., Hanada S, Takewa Y, Mizuno T, Tsukiya T, Taenaka Y, Tatsumi E. *, J Artif Organs. , Jun;15(2):140-5. 2012

  56. Coronary vascular resistance increases under full bypass support of centrifugal pumps--relation between myocardial perfusion and ventricular workload during pump support., Ando M, Takewa Y, Nishimura T, Yamazaki K, Kyo S, Ono M, Tsukiya T, Mizuno T, Taenaka Y, Tatsumi E. *, Artif Organs., Jan;36(1):105-10. 2012

  57. Development and hydrodynamic evaluation of a novel inflow cannula in a mechanical circulatory support system for bridge to decision., Sumikura H, Toda K, Takewa Y, Tsukiya T, Ohnuma K, Sasagawa M, Watanabe F, Ugawa J, Taenaka Y, Tatsumi E. *, Artif Organs., Aug;35(8):756-64. 2011

  58. Computational fluid dynamic analysis of the flow field in the newly developed inflow cannula for a bridge-to-decision mechanical circulatory support., Tsukiya T, Toda K, Sumikura H, Takewa Y, Watanabe F, Taenaka Y, Tatsumi E. *, J Artif Organs. , Dec;14(4):381-4. 2011

  59. Development and long-term in vivo testing of a novel skin-button system for preventing driveline infection of an implantable VAD system., Mizuno T, Nemoto Y, Tsukiya T, Takewa Y, Taenaka Y, Tatsumi E. *, J Artif Organs. , Dec;14(4):371-4. 2011

  60. A novel counterpulsation mode of rotary left ventricular assist devices can enhance myocardial perfusion., Ando M, Takewa Y, Nishimura T, Yamazaki K, Kyo S, Ono M, Tsukiya T, Mizuno T, Taenaka Y, Tatsumi E. *, J Artif Organs. , Sep;14(3):185-91. 2011

  61. Electrocardiogram-synchronized rotational speed change mode in rotary pumps could improve pulsatility., Ando M, Nishimura T, Takewa Y, Yamazaki K, Kyo S, Ono M, Tsukiya T, Mizuno T, Taenaka Y, Tatsumi E. *, Artif Organs. , Oct;35(10):941-7. 2011

  62. Development of a preclinical model of ischemic cardiomyopathy in swine., Ishikawa K, Ladage D, Takewa Y, Yaniz E, Chen J, Tilemann L, Sakata S, Badimon JJ, Hajjar RJ, Kawase Y. *, Am J Physiol Heart Circ Physiol., Aug;301(2):H530-7. 2011

  63. Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model., Ladage D, Turnbull IC, Ishikawa K, Takewa Y, Rapti K, Morel C, Karakikes I, Hadri L, Muller-Ehmsen J, Costa KD, Hajjar RJ, Kawase Y. *, Gene Ther. 2011 Oct;18(10):979-85. 　 [IF, 3.203; citation, 34], Oct;18(10):979-85. 2011

  64. What is the ideal off-test trial for continuous-flow ventricular-assist-device explantation? Intracircuit back-flow analysis in a mock circulation model., Ando M, Nishimura T, Takewa Y, Ogawa D, Yamazaki K, Kashiwa K, Kyo S, Ono M, Taenaka Y, Tatsumi E. *, J Artif Organs. , Mar;14(1):70-3. 2011

  65. A novel counterpulse drive mode of continuous-flow left ventricular assist devices can minimize intracircuit backward flow during pump weaning., Ando M, Nishimura T, Takewa Y, Ogawa D, Yamazaki K, Kashiwa K, Kyo S, Ono M, Taenaka Y, Tatsumi E. *, J Artif Organs. , Mar;14(1):74-9. 2011

  66. Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats., Takewa Y, Chemaly ER, Takaki M, Liang LF, Jin H, Karakikes I, Morel C, Taenaka Y, Tatsumi E, Hajjar RJ. *, Am J Physiol Heart Circ Physiol., Apr;296(4):H1117-24. 2009

  67. Impact of molecular weight in four-branched star vectors with narrow molecular weight distribution on gene delivery efficiency., Nemoto Y, Borovkov A, Zhou YM, Takewa Y, Tatsumi E, Nakayama Y. *, Bioconjug Chem., Dec;20(12):2293-9. 2009

  68. In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction., Ly HQ, Hoshino K, Pomerantseva I, Kawase Y, Yoneyama R, Takewa Y, Fortier A, Gibbs-Strauss SL, Vooght C, Frangioni JV, Hajjar RJ. *, Eur Heart J., Dec;30(23):2861-8. 2009

  69. Development of a compact wearable pneumatic drive unit for a ventricular assist device., Homma A, Taenaka Y, *Tatsumi E, Akagawa E, Lee H, Nishinaka T, Takewa Y, Mizuno T, Tsukiya T, Kakuta Y, Katagiri N, Shimosaki I, Hamada S, Mukaibayashi H, Iwaoka W., J Artif Organs., 11(4):182-90. 2008

  70. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure., Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, Tanguay JF, Hajjar RJ. *, J Am Coll Cardiol., Mar 18;51(11):1112-9. 2008

  71. Preservation of mechanical and energetic function after adenoviral gene transfer in normal rat hearts., Sakata S, Liang L, Sakata N, Sakata Y, Chemaly ER, Lebeche D, Takewa Y, Chen J, Park WJ, Kawase Y, Hajjar RJ. *, Clin Exp Pharmacol Physiol., Dec;34(12):1300-6. 2007

  72. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins., Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, Tsuji T, Takewa Y, del Monte F, Peluso R, Zsebo K, Jeong D, Park WJ, Kawase Y, Hajjar RJ. *, J Mol Cell Cardiol., Apr;42(4):852-61. 2007

  73. Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts., Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, Takewa Y, Jeong D, Park WJ, Kawase Y, Hajjar RJ. *, Am J Physiol Heart Circ Physiol., May;292(5):H2356-63. 2007

  74. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices., Shirakawa Y, Sawa Y, Takewa Y, Tatsumi E, Kaneda Y, Taenaka Y, Matsuda H. *, J Thorac Cardiovasc Surg. , Sep;130(3):624-32. 2005

  75. Observation of cavitation bubbles in monoleaflet mechanical heart valves., Lee H, Tsukiya T, Homma A, Kamimura T, Takewa Y, Tatsumi E, Taenaka Y, *Takano H, Kitamura S., J Artif Organs. , 7(3):121-7. 2004

  76. Observation of alveolar fibrosis in a goat following venoarterial bypass for up to 5 months using extracorporeal membrane oxygenation., Mizuno T, Tatsumi E, Nishinaka T, Katagiri N, Ohikawa M, Naito H, Shirakawa Y, Tsukiya T, Homma A, Takewa Y, Takano H, Kitamura S, Taenaka Y. *, J Artif Organs. , 7(2):107-9. 2004

  77. Three-dimensional cardiac tissue engineering using a thermoresponsive artificial extracellular matrix., Naito H, Takewa Y, Mizuno T, Ohya S, Nakayama Y, Tatsumi E, Kitamura S, Takano H, Taniguchi S, Taenaka Y. *, ASAIO J., Jul-Aug;50(4):344-8. 2004

  78. Observation of cavitation in a mechanical heart valve in a total artificial heart., Lee H, Tsukiya T, Homma A, Kamimura T, Takewa Y, Nishinaka T, Tatsumi E, Taenaka Y, *Takano H, Kitamura S., ASAIO J., May-Jun;50(3):205-10. 2004

  79. Design progress of the ultracompact integrated heart lung assist device--part 2: optimization of the diffuser vane profile., Tsukiya T, Tatsumi E, Nishinaka T, Katagiri N, Takewa Y, Ohnishi H, Oshikawa M, Mizuno T, Taenaka Y, *Takano H, Kitamura S., Artif Organs., Oct;27(10):914-9. 2003

  80. Design progress of the ultracompact integrated heart lung assist device--part 1: effect of vaned diffusers on gas-transfer performances., Tsukiya T, Tatsumi E, Nishinaka T, Katagiri N, Takewa Y, Ohnishi H, Oshikawa M, Shioya K, Mizuno T, Taenaka Y, *Takano H, Kitamura S., Artif Organs., Oct;27(10):907-13. 2003

  81. The roles of vascular smooth muscle cells in the aortic wall thinness under prolonged continuous flow left heart bypass., Mizuno T, Nishinaka T, Ohnishi H, Tatsumi E, Tsukiya T, Oshikawa M, Shioya K, Takewa Y, Homma A, Takano H, Kitamura S, Taenaka Y. *, Artif Organs., Oct;27(10):882-6. 2003

  82. The National Cardiovascular Center electrohydraulic total artificial heart and ventricular assist device systems: current status of development., Tatsumi E, Taenaka Y, *Homma A, Nishinaka T, Takewa Y, Tsukiya T, Ohnishi H, Oshikawa M, Shirakawa Y, Kakuta Y, Shioya K, Katagiri N, Mizuno T, Kamimura T, Takano H, Tsukahara K, Tsuchimoto K, Wakui H, Yamaguchi H., ASAIO J., May-Jun;49(3):243-9. 2003

  83. Prostaglandin Synthesis Inhibitor Affects Humoral Conditions And Oxygen Metabolism During Normothermic Cardiopulmonary Bypass, Takewa Y, Taenaka Y, *Tatsumi E, Sato K, Ohnishi H, Oshikawa M, Nishinaka T, Takano H., Artif Organs., Aug;26(8):676-81. 2002

  84. Ultrastructural alterations in red blood cell membranes exposed to shear stress., Mizuno T, Tsukiya T, Taenaka Y, *Tatsumi E, Nishinaka T, Ohnishi H, Oshikawa M, Sato K, Shioya K, Takewa Y, Takano H., ASAIO J., Nov-Dec;48(6):668-70. 2002

  85. Morphological changes of the arterial systems in the kidney under prolonged continuous flow left heart bypass., Ohnishi H, Itoh T, Nishinaka T, Tatsumi E, Fukuda T, Oshikawa M, Shioya K, Tsukiya T, Takewa Y, Homma A, Uesho K, Sato K, Takano H, Taenaka Y. *, Artif Organs., Nov;26(11):974-9. 2002

  86. Prostaglandin synthesis inhibitor prevents hypotension without impairing gut perfusion during normothermic cardiopulmonary bypass., Sato K, Takewa Y, Taenaka Y, Tatsumi E, Nishinaka T, Shioya K, Fukuda T, Ohnishi H, Oshikawa M, Uesho K, Takano H, Hayashi J. *, ASAIO J., Sep-Oct;48(5):503-7. 2002

  87. At least thirty-four days of animal continuous perfusion by a newly developed extracorporeal membrane oxygenation system without systemic anticoagulants., Nishinaka T, Tatsumi E, Taenaka Y, *Katagiri N, Ohnishi H, Shioya K, Fukuda T, Oshikawa M, Sato K, Tsukiya T, Homma A, Takewa Y, Takano H, Sato M, Kashiwabara S, Tanaka H, Sakai K, Matsuda T., Artif Organs., Jun;26(6):548-51. 2002

  88. Prostaglandin synthesis inhibitor improves hypotension during normothermic cardiopulmonary bypass, Takewa Y, Seki T, Tatsumi E, Taenaka Y, *Takano H, ASAIO J., Nov-Dec;47(6):673-6. 2001

  89. Oxygen metabolism under various bypass flow conditions during cardiopulmonary support in awake goats, Takewa Y, Tatsumi E, Taenaka Y, *Takano H, Int J Artif Organs., Feb;24(2):83-8. 2001

  90. Regulation of perfusion pressure during cardiopulmonary bypass using sevoflurane., Ueda T, Mizuguchi K, Tsuji T, Tabayashi N, Abe T, Naito H, Takewa Y, Taniguchi S. *, Int J Artif Organs., Jan;24(1):30-3. 2001

  91. Hemodynamic effects of prostaglandins and catecholamines in graded reduction of pulmonary flow during venoarterial bypass in awake goats., Takewa Y, Tatsumi E, Taenaka Y, Nishimura T, Nakamura M, Endo S, Takano H, Kitamura S, Mizuguchi K, Taniguchi S., ASAIO J., Jan-Feb;45(1):79-82. 1999

  92. Prolonged nonpulsatile left heart bypass with reduced systemic pulse pressure causes morphological changes in the aortic wall., Nishimura T, Tatsumi E, Takaichi S, Taenaka Y, Wakisaka Y, Nakatani T, Masuzawa T, Takewa Y, Nakamura M, Endo S, Nakata M, Takano H., Artif Organs., May;22(5):405-10. 1998

  93. Hemodynamic and humoral conditions in stepwise reduction of pulmonary blood flow during venoarterial bypass in awake goats, Takewa Y, Tatsumi E, Taenaka Y, Eya K, Nakatani T, Nishimura T, Sohn YS, Masuzawa T, Wakisaka Y, Nakamura M, Endo S, Takano H, Kitamura S. *, ASAIO J., Sep-Oct;43(5):M494-9. 1997

  94. Morphologic changes of the aortic wall due to reduced systemic pulse pressure in prolonged non pulsatile left heart bypass., Nishimura T, Tatsumi E, Takaichi S, Taenaka Y, *Wakisaka Y, Nakatani T, Masuzawa T, Takewa Y, Nakamura M, Endo S, Sohn YS, Takano H., ASAIO J., Sep-Oct;43(5):M691-5. 1997

  95. Characteristics of mixed venous oxygen saturation and physical activity as parameters for artificial heart control., Ohno T, Masuzawa T, Nakamura M, Tatsumi E, Taenaka Y, *Nakatani T, Wakisaka Y, Nishimura T, Takewa Y, Takano H, Fukui Y., ASAIO J., Sep-Oct;43(5):M677-81. 1997

  96. Early changes in circulating blood volume and volume regulating humoral factors after implantation of an electrohydraulic total artificial heart., Nakamura M, Tatsumi E, Masuzawa T, Taenaka Y, *Nakatani T, Sohn Y, Endo S, Ohno T, Takiura K, Nishimura T, Takewa Y, Wakisaka Y, Takano H., ASAIO J., Sep-Oct;43(5):M663-8. 1997

  97. In vitro and in vivo evaluation of a left-right balancing capacity of an interatrial shunt in an electrohydraulic total artificial heart system., Tatsumi E, Nakamura M, Masuzawa T, Taenaka Y, Sohn YS, Nishimura T, Nakata M, Nakatani T, Ohno T, Endo S, Takiura K, Takewa Y, Kakuta Y, Takano H. *, ASAIO J., Sep-Oct;43(5):M619-25. 1997

  98. In vitro and in vivo heat dissipation of an electrohydraulic totally implantable artificial heart., Endo S, Masuzawa T, Tatsumi E, Taenaka Y, Nakatani T, Ohno T, Wakisaka Y, Nishimura T, Takewa Y, Nakamura M, Takiura K, Sohn YS, Takano H. *, ASAIO J., Sep-Oct;43(5):M592-7. 1997

  99. Noninvasive pump flow estimation of a centrifugal blood pump., Wakisaka Y, Okuzono Y, Taenaka Y, Chikanari K, Masuzawa T, Nakatani T, Tatsumi E, Nishimura T, Takewa Y, Ohno T, Takano H. *, Artif Organs., Jul;21(7):651-4. 1997

  100. Long-term evaluation of a nonpulsatile mechanical circulatory support system., Wakisaka Y, Taenaka Y, Chikanari K, Nakatani T, Tatsumi E, Masuzawa T, Nishimura T, Takewa Y, Ohno T, Takano H. *, Artif Organs., Jul;21(7):639-44. 1997

  101. Altered oxygen metabolic conditions associated with increased norepinephrine levels in a nonpulsatile systemic circulation., Tatsumi E, Miyazaki K, Toda K, Taenaka Y, Nakatani T, Baba Y, Masuzawa T, Eya K, Wakisaka Y, Nishimura T, Takewa Y, Ohno T, Takano H. *, ASAIO J., Sep-Oct;42(5):M854-8. 1996

  102. Development of a membrane oxygenator for long-term respiratory support and its experimental evaluation in prolonged ECMO., Eya K, Tatsumi E, Taenaka Y, *Takewa Y, Wakisaka Y, Toda K, Nakatani T, Masuzawa T, Baba Y, Miyazaki K, Nishimura T, Ohno T, Ahn JM, Takano H, Mimura R, Tanaka S, Wada T., ASAIO J., Sep-Oct;42(5):M832-6. 1996

  103. Development of an integrated artificial heart-lung device for long-term cardiopulmonary support., Tatsumi E, Takewa Y, Akagi H, Taenaka Y, * Eya K, Nakatani T, Baba Y, Masuzawa T, Wakisaka Y, Toda K, Miyazaki K, Nishimura T, Ohno T, Takano H., ASAIO J., Sep-Oct;42(5):M827-32. 1996

  104. Importance of metabolic function of the natural lung evaluated by prolonged exclusion of the pulmonary circulation., Eya K, Tatsumi E, Taenaka Y, Takewa Y, Toda K, Wakisaka Y, Nakatani T, Masuzawa T, Baba Y, Miyazaki K, Nishimura T, Ohno T, Ahn JM, Akagi H, Takano H. *, ASAIO J., Sep-Oct;42(5):M805-9. 1996

  105. Influence of non pulsatile systemic circulation on tissue blood flow and oxygen metabolism., Tatsumi E, Miyazaki K, Toda K, Taenaka Y, Nakatani T, Baba Y, Masuzawa T, Wakisaka Y, Eya K, Nishimura T, Takewa Y, Ohno T, Takano H. *, ASAIO J. , Sep-Oct;42(5):M757-62. 1996

  106. Tandem operation of a turbo blood pump (BP-80--type centrifugal pump) to reduce hemolysis., Wakisaka Y, Taenaka Y, Nakatani T, Anai H, Araki K, Nishimura T, Tatsumi E, Masuzawa T, Baba Y, Toda K, Eya K, Miyazaki K, Takewa Y, Takano H. *, Artif Organs., Jun;20(6):572-4. 1996

  107. Tandem Operation of a Turbo Blood Pump (BP-80-Type Centrifugal Pump) to Reduce Hemolysis., Wakisaka Y, Taenaka Y, Nakatani T, Anai H, Araki K, Nishimura T, Tatsumi E, Masuzawa T, Baba Y, Toda K, Eya K, Miyazaki K, Takewa Y, Takano H. *, Artif Organs., May;20(5):572-574. 1996